nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—DHFR—Methotrexate—urinary bladder cancer	0.332	0.537	CbGbCtD
Proguanil—CYP3A4—Thiotepa—urinary bladder cancer	0.0594	0.0961	CbGbCtD
Proguanil—CYP2E1—Etoposide—urinary bladder cancer	0.0532	0.086	CbGbCtD
Proguanil—CYP1A2—Fluorouracil—urinary bladder cancer	0.0368	0.0596	CbGbCtD
Proguanil—CYP2C9—Fluorouracil—urinary bladder cancer	0.0332	0.0537	CbGbCtD
Proguanil—CYP1A2—Etoposide—urinary bladder cancer	0.0307	0.0498	CbGbCtD
Proguanil—CYP2C9—Cisplatin—urinary bladder cancer	0.0282	0.0456	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—urinary bladder cancer	0.0173	0.028	CbGbCtD
Proguanil—CYP3A4—Etoposide—urinary bladder cancer	0.0161	0.0261	CbGbCtD
Proguanil—CYP3A4—Doxorubicin—urinary bladder cancer	0.011	0.0178	CbGbCtD
Proguanil—CYP2C19—urine—urinary bladder cancer	0.00687	0.106	CbGeAlD
Proguanil—CYP1A2—urine—urinary bladder cancer	0.00561	0.0868	CbGeAlD
Proguanil—CYP2C9—urine—urinary bladder cancer	0.00532	0.0824	CbGeAlD
Proguanil—CYP2E1—urine—urinary bladder cancer	0.00505	0.0781	CbGeAlD
Proguanil—Amylase increased—Thiotepa—urinary bladder cancer	0.00446	0.035	CcSEcCtD
Proguanil—DHFR—prostate gland—urinary bladder cancer	0.00433	0.0671	CbGeAlD
Proguanil—CYP3A4—urine—urinary bladder cancer	0.00406	0.0628	CbGeAlD
Proguanil—CYP2D6—urine—urinary bladder cancer	0.004	0.0618	CbGeAlD
Proguanil—DHFR—seminal vesicle—urinary bladder cancer	0.00367	0.0567	CbGeAlD
Proguanil—Amylase increased—Cisplatin—urinary bladder cancer	0.0035	0.0275	CcSEcCtD
Proguanil—DHFR—renal system—urinary bladder cancer	0.00295	0.0457	CbGeAlD
Proguanil—DHFR—urethra—urinary bladder cancer	0.0029	0.0449	CbGeAlD
Proguanil—Pancytopenia—Mitomycin—urinary bladder cancer	0.00252	0.0198	CcSEcCtD
Proguanil—DHFR—female reproductive system—urinary bladder cancer	0.00237	0.0366	CbGeAlD
Proguanil—Stomatitis—Mitomycin—urinary bladder cancer	0.0023	0.0181	CcSEcCtD
Proguanil—DHFR—vagina—urinary bladder cancer	0.00214	0.0331	CbGeAlD
Proguanil—Hepatic enzyme increased—Gemcitabine—urinary bladder cancer	0.00189	0.0148	CcSEcCtD
Proguanil—Erythema—Mitomycin—urinary bladder cancer	0.00185	0.0145	CcSEcCtD
Proguanil—CYP2E1—prostate gland—urinary bladder cancer	0.00181	0.028	CbGeAlD
Proguanil—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00179	0.014	CcSEcCtD
Proguanil—Abdominal pain—Valrubicin—urinary bladder cancer	0.00173	0.0136	CcSEcCtD
Proguanil—Body temperature increased—Valrubicin—urinary bladder cancer	0.00173	0.0136	CcSEcCtD
Proguanil—Cough—Mitomycin—urinary bladder cancer	0.00161	0.0127	CcSEcCtD
Proguanil—Body temperature increased—Carboplatin—urinary bladder cancer	0.0016	0.0126	CcSEcCtD
Proguanil—CYP2E1—seminal vesicle—urinary bladder cancer	0.00153	0.0237	CbGeAlD
Proguanil—Diarrhoea—Valrubicin—urinary bladder cancer	0.0015	0.0118	CcSEcCtD
Proguanil—Anorexia—Mitomycin—urinary bladder cancer	0.00144	0.0113	CcSEcCtD
Proguanil—Vomiting—Valrubicin—urinary bladder cancer	0.00139	0.0109	CcSEcCtD
Proguanil—DHFR—lymph node—urinary bladder cancer	0.00138	0.0214	CbGeAlD
Proguanil—Rash—Valrubicin—urinary bladder cancer	0.00138	0.0108	CcSEcCtD
Proguanil—Dermatitis—Valrubicin—urinary bladder cancer	0.00138	0.0108	CcSEcCtD
Proguanil—CYP1A2—renal system—urinary bladder cancer	0.00137	0.0212	CbGeAlD
Proguanil—Headache—Valrubicin—urinary bladder cancer	0.00137	0.0108	CcSEcCtD
Proguanil—Decreased appetite—Mitomycin—urinary bladder cancer	0.00131	0.0103	CcSEcCtD
Proguanil—Nausea—Valrubicin—urinary bladder cancer	0.0013	0.0102	CcSEcCtD
Proguanil—Pancytopenia—Thiotepa—urinary bladder cancer	0.00127	0.00994	CcSEcCtD
Proguanil—CYP2E1—renal system—urinary bladder cancer	0.00123	0.0191	CbGeAlD
Proguanil—CYP2C19—vagina—urinary bladder cancer	0.00122	0.0188	CbGeAlD
Proguanil—CYP2E1—urethra—urinary bladder cancer	0.00121	0.0188	CbGeAlD
Proguanil—Body temperature increased—Mitomycin—urinary bladder cancer	0.00119	0.00936	CcSEcCtD
Proguanil—Stomatitis—Thiotepa—urinary bladder cancer	0.00116	0.0091	CcSEcCtD
Proguanil—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00112	0.00883	CcSEcCtD
Proguanil—Pancytopenia—Gemcitabine—urinary bladder cancer	0.00106	0.00836	CcSEcCtD
Proguanil—Hallucination—Thiotepa—urinary bladder cancer	0.00106	0.00834	CcSEcCtD
Proguanil—Pancytopenia—Fluorouracil—urinary bladder cancer	0.00105	0.00822	CcSEcCtD
Proguanil—CYP2C9—female reproductive system—urinary bladder cancer	0.00104	0.0161	CbGeAlD
Proguanil—Diarrhoea—Mitomycin—urinary bladder cancer	0.00103	0.0081	CcSEcCtD
Proguanil—CYP3A4—renal system—urinary bladder cancer	0.000993	0.0154	CbGeAlD
Proguanil—Pancytopenia—Cisplatin—urinary bladder cancer	0.000992	0.00779	CcSEcCtD
Proguanil—CYP2E1—female reproductive system—urinary bladder cancer	0.000989	0.0153	CbGeAlD
Proguanil—CYP2D6—renal system—urinary bladder cancer	0.000978	0.0151	CbGeAlD
Proguanil—Stomatitis—Gemcitabine—urinary bladder cancer	0.000974	0.00765	CcSEcCtD
Proguanil—Hepatic enzyme increased—Methotrexate—urinary bladder cancer	0.000966	0.00759	CcSEcCtD
Proguanil—Immune system disorder—Thiotepa—urinary bladder cancer	0.000964	0.00757	CcSEcCtD
Proguanil—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.000961	0.00755	CcSEcCtD
Proguanil—Vomiting—Mitomycin—urinary bladder cancer	0.000958	0.00753	CcSEcCtD
Proguanil—Stomatitis—Fluorouracil—urinary bladder cancer	0.000958	0.00752	CcSEcCtD
Proguanil—Rash—Mitomycin—urinary bladder cancer	0.00095	0.00746	CcSEcCtD
Proguanil—Dermatitis—Mitomycin—urinary bladder cancer	0.000949	0.00746	CcSEcCtD
Proguanil—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.000945	0.00742	CcSEcCtD
Proguanil—Headache—Mitomycin—urinary bladder cancer	0.000944	0.00741	CcSEcCtD
Proguanil—Mental disorder—Thiotepa—urinary bladder cancer	0.000935	0.00734	CcSEcCtD
Proguanil—Malnutrition—Thiotepa—urinary bladder cancer	0.000929	0.00729	CcSEcCtD
Proguanil—Erythema—Thiotepa—urinary bladder cancer	0.000929	0.00729	CcSEcCtD
Proguanil—Pancytopenia—Etoposide—urinary bladder cancer	0.000909	0.00714	CcSEcCtD
Proguanil—Stomatitis—Cisplatin—urinary bladder cancer	0.000908	0.00713	CcSEcCtD
Proguanil—Nausea—Mitomycin—urinary bladder cancer	0.000895	0.00703	CcSEcCtD
Proguanil—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.000881	0.00692	CcSEcCtD
Proguanil—Stomatitis—Etoposide—urinary bladder cancer	0.000832	0.00653	CcSEcCtD
Proguanil—Immune system disorder—Gemcitabine—urinary bladder cancer	0.000811	0.00637	CcSEcCtD
Proguanil—Cough—Thiotepa—urinary bladder cancer	0.00081	0.00636	CcSEcCtD
Proguanil—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.000809	0.00635	CcSEcCtD
Proguanil—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.000807	0.00634	CcSEcCtD
Proguanil—CYP3A4—female reproductive system—urinary bladder cancer	0.000796	0.0123	CbGeAlD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000785	0.00617	CcSEcCtD
Proguanil—CYP2D6—female reproductive system—urinary bladder cancer	0.000783	0.0121	CbGeAlD
Proguanil—Erythema—Gemcitabine—urinary bladder cancer	0.000781	0.00614	CcSEcCtD
Proguanil—Erythema—Fluorouracil—urinary bladder cancer	0.000768	0.00603	CcSEcCtD
Proguanil—Immune system disorder—Cisplatin—urinary bladder cancer	0.000756	0.00593	CcSEcCtD
Proguanil—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.000754	0.00592	CcSEcCtD
Proguanil—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000743	0.00584	CcSEcCtD
Proguanil—Skin disorder—Thiotepa—urinary bladder cancer	0.000736	0.00578	CcSEcCtD
Proguanil—Malnutrition—Cisplatin—urinary bladder cancer	0.000728	0.00572	CcSEcCtD
Proguanil—Erythema—Cisplatin—urinary bladder cancer	0.000728	0.00572	CcSEcCtD
Proguanil—Anorexia—Thiotepa—urinary bladder cancer	0.000722	0.00567	CcSEcCtD
Proguanil—Immune system disorder—Etoposide—urinary bladder cancer	0.000692	0.00544	CcSEcCtD
Proguanil—Mediastinal disorder—Etoposide—urinary bladder cancer	0.000691	0.00542	CcSEcCtD
Proguanil—Cough—Gemcitabine—urinary bladder cancer	0.000682	0.00535	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000661	0.00519	CcSEcCtD
Proguanil—Decreased appetite—Thiotepa—urinary bladder cancer	0.000659	0.00517	CcSEcCtD
Proguanil—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000654	0.00514	CcSEcCtD
Proguanil—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000625	0.00491	CcSEcCtD
Proguanil—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00062	0.00487	CcSEcCtD
Proguanil—Skin disorder—Gemcitabine—urinary bladder cancer	0.000619	0.00486	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000616	0.00483	CcSEcCtD
Proguanil—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000615	0.00483	CcSEcCtD
Proguanil—Anorexia—Gemcitabine—urinary bladder cancer	0.000608	0.00477	CcSEcCtD
Proguanil—Abdominal pain—Thiotepa—urinary bladder cancer	0.000599	0.00471	CcSEcCtD
Proguanil—Body temperature increased—Thiotepa—urinary bladder cancer	0.000599	0.00471	CcSEcCtD
Proguanil—Anorexia—Fluorouracil—urinary bladder cancer	0.000598	0.00469	CcSEcCtD
Proguanil—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000583	0.00458	CcSEcCtD
Proguanil—Cough—Etoposide—urinary bladder cancer	0.000582	0.00457	CcSEcCtD
Proguanil—Skin disorder—Cisplatin—urinary bladder cancer	0.000577	0.00453	CcSEcCtD
Proguanil—Anorexia—Cisplatin—urinary bladder cancer	0.000566	0.00445	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000564	0.00443	CcSEcCtD
Proguanil—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000554	0.00435	CcSEcCtD
Proguanil—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00055	0.00432	CcSEcCtD
Proguanil—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000545	0.00428	CcSEcCtD
Proguanil—Pancytopenia—Methotrexate—urinary bladder cancer	0.000545	0.00428	CcSEcCtD
Proguanil—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000541	0.00425	CcSEcCtD
Proguanil—Skin disorder—Etoposide—urinary bladder cancer	0.000529	0.00415	CcSEcCtD
Proguanil—Anorexia—Etoposide—urinary bladder cancer	0.000519	0.00408	CcSEcCtD
Proguanil—Diarrhoea—Thiotepa—urinary bladder cancer	0.000519	0.00407	CcSEcCtD
Proguanil—Decreased appetite—Cisplatin—urinary bladder cancer	0.000517	0.00406	CcSEcCtD
Proguanil—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000513	0.00403	CcSEcCtD
Proguanil—Pancytopenia—Epirubicin—urinary bladder cancer	0.00051	0.004	CcSEcCtD
Proguanil—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000504	0.00396	CcSEcCtD
Proguanil—Stomatitis—Methotrexate—urinary bladder cancer	0.000498	0.00391	CcSEcCtD
Proguanil—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000496	0.00389	CcSEcCtD
Proguanil—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000484	0.0038	CcSEcCtD
Proguanil—Vomiting—Thiotepa—urinary bladder cancer	0.000482	0.00378	CcSEcCtD
Proguanil—Rash—Thiotepa—urinary bladder cancer	0.000478	0.00375	CcSEcCtD
Proguanil—Dermatitis—Thiotepa—urinary bladder cancer	0.000477	0.00375	CcSEcCtD
Proguanil—Headache—Thiotepa—urinary bladder cancer	0.000475	0.00373	CcSEcCtD
Proguanil—Decreased appetite—Etoposide—urinary bladder cancer	0.000473	0.00372	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000472	0.0037	CcSEcCtD
Proguanil—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00047	0.00369	CcSEcCtD
Proguanil—Body temperature increased—Cisplatin—urinary bladder cancer	0.00047	0.00369	CcSEcCtD
Proguanil—Stomatitis—Epirubicin—urinary bladder cancer	0.000466	0.00366	CcSEcCtD
Proguanil—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000453	0.00355	CcSEcCtD
Proguanil—Nausea—Thiotepa—urinary bladder cancer	0.00045	0.00354	CcSEcCtD
Proguanil—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000445	0.0035	CcSEcCtD
Proguanil—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000436	0.00343	CcSEcCtD
Proguanil—Stomatitis—Doxorubicin—urinary bladder cancer	0.000432	0.00339	CcSEcCtD
Proguanil—Abdominal pain—Etoposide—urinary bladder cancer	0.00043	0.00338	CcSEcCtD
Proguanil—Body temperature increased—Etoposide—urinary bladder cancer	0.00043	0.00338	CcSEcCtD
Proguanil—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000429	0.00337	CcSEcCtD
Proguanil—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000419	0.00329	CcSEcCtD
Proguanil—Immune system disorder—Methotrexate—urinary bladder cancer	0.000415	0.00326	CcSEcCtD
Proguanil—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000414	0.00325	CcSEcCtD
Proguanil—Diarrhoea—Cisplatin—urinary bladder cancer	0.000407	0.00319	CcSEcCtD
Proguanil—Vomiting—Gemcitabine—urinary bladder cancer	0.000405	0.00318	CcSEcCtD
Proguanil—Mental disorder—Methotrexate—urinary bladder cancer	0.000402	0.00316	CcSEcCtD
Proguanil—Rash—Gemcitabine—urinary bladder cancer	0.000402	0.00316	CcSEcCtD
Proguanil—Dermatitis—Gemcitabine—urinary bladder cancer	0.000402	0.00315	CcSEcCtD
Proguanil—Erythema—Methotrexate—urinary bladder cancer	0.0004	0.00314	CcSEcCtD
Proguanil—Malnutrition—Methotrexate—urinary bladder cancer	0.0004	0.00314	CcSEcCtD
Proguanil—Headache—Gemcitabine—urinary bladder cancer	0.000399	0.00314	CcSEcCtD
Proguanil—Vomiting—Fluorouracil—urinary bladder cancer	0.000399	0.00313	CcSEcCtD
Proguanil—Rash—Fluorouracil—urinary bladder cancer	0.000395	0.0031	CcSEcCtD
Proguanil—Dermatitis—Fluorouracil—urinary bladder cancer	0.000395	0.0031	CcSEcCtD
Proguanil—Headache—Fluorouracil—urinary bladder cancer	0.000393	0.00308	CcSEcCtD
Proguanil—Immune system disorder—Epirubicin—urinary bladder cancer	0.000388	0.00305	CcSEcCtD
Proguanil—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000387	0.00304	CcSEcCtD
Proguanil—Nausea—Gemcitabine—urinary bladder cancer	0.000379	0.00297	CcSEcCtD
Proguanil—Vomiting—Cisplatin—urinary bladder cancer	0.000378	0.00297	CcSEcCtD
Proguanil—Mental disorder—Epirubicin—urinary bladder cancer	0.000376	0.00296	CcSEcCtD
Proguanil—Rash—Cisplatin—urinary bladder cancer	0.000375	0.00294	CcSEcCtD
Proguanil—Dermatitis—Cisplatin—urinary bladder cancer	0.000374	0.00294	CcSEcCtD
Proguanil—Malnutrition—Epirubicin—urinary bladder cancer	0.000374	0.00294	CcSEcCtD
Proguanil—Erythema—Epirubicin—urinary bladder cancer	0.000374	0.00294	CcSEcCtD
Proguanil—Diarrhoea—Etoposide—urinary bladder cancer	0.000373	0.00293	CcSEcCtD
Proguanil—Nausea—Fluorouracil—urinary bladder cancer	0.000372	0.00292	CcSEcCtD
Proguanil—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000359	0.00282	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000358	0.00281	CcSEcCtD
Proguanil—Nausea—Cisplatin—urinary bladder cancer	0.000353	0.00277	CcSEcCtD
Proguanil—Cough—Methotrexate—urinary bladder cancer	0.000349	0.00274	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—urinary bladder cancer	0.000348	0.00273	CcSEcCtD
Proguanil—Vomiting—Etoposide—urinary bladder cancer	0.000346	0.00272	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—urinary bladder cancer	0.000346	0.00272	CcSEcCtD
Proguanil—Erythema—Doxorubicin—urinary bladder cancer	0.000346	0.00272	CcSEcCtD
Proguanil—Rash—Etoposide—urinary bladder cancer	0.000343	0.0027	CcSEcCtD
Proguanil—Dermatitis—Etoposide—urinary bladder cancer	0.000343	0.00269	CcSEcCtD
Proguanil—Headache—Etoposide—urinary bladder cancer	0.000341	0.00268	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000338	0.00265	CcSEcCtD
Proguanil—Cough—Epirubicin—urinary bladder cancer	0.000326	0.00256	CcSEcCtD
Proguanil—Nausea—Etoposide—urinary bladder cancer	0.000323	0.00254	CcSEcCtD
Proguanil—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00032	0.00251	CcSEcCtD
Proguanil—Skin disorder—Methotrexate—urinary bladder cancer	0.000317	0.00249	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000316	0.00248	CcSEcCtD
Proguanil—Anorexia—Methotrexate—urinary bladder cancer	0.000311	0.00244	CcSEcCtD
Proguanil—Cough—Doxorubicin—urinary bladder cancer	0.000302	0.00237	CcSEcCtD
Proguanil—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000299	0.00235	CcSEcCtD
Proguanil—Skin disorder—Epirubicin—urinary bladder cancer	0.000296	0.00233	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000293	0.0023	CcSEcCtD
Proguanil—Anorexia—Epirubicin—urinary bladder cancer	0.000291	0.00228	CcSEcCtD
Proguanil—Decreased appetite—Methotrexate—urinary bladder cancer	0.000283	0.00223	CcSEcCtD
Proguanil—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000282	0.00221	CcSEcCtD
Proguanil—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000277	0.00217	CcSEcCtD
Proguanil—Skin disorder—Doxorubicin—urinary bladder cancer	0.000274	0.00215	CcSEcCtD
Proguanil—Anorexia—Doxorubicin—urinary bladder cancer	0.000269	0.00211	CcSEcCtD
Proguanil—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000267	0.00209	CcSEcCtD
Proguanil—Decreased appetite—Epirubicin—urinary bladder cancer	0.000265	0.00208	CcSEcCtD
Proguanil—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000263	0.00207	CcSEcCtD
Proguanil—Abdominal pain—Methotrexate—urinary bladder cancer	0.000258	0.00202	CcSEcCtD
Proguanil—Body temperature increased—Methotrexate—urinary bladder cancer	0.000258	0.00202	CcSEcCtD
Proguanil—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00025	0.00196	CcSEcCtD
Proguanil—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000245	0.00193	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000244	0.00191	CcSEcCtD
Proguanil—Abdominal pain—Epirubicin—urinary bladder cancer	0.000241	0.00189	CcSEcCtD
Proguanil—Body temperature increased—Epirubicin—urinary bladder cancer	0.000241	0.00189	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000231	0.00181	CcSEcCtD
Proguanil—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000223	0.00175	CcSEcCtD
Proguanil—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000223	0.00175	CcSEcCtD
Proguanil—Diarrhoea—Methotrexate—urinary bladder cancer	0.000223	0.00175	CcSEcCtD
Proguanil—Diarrhoea—Epirubicin—urinary bladder cancer	0.000209	0.00164	CcSEcCtD
Proguanil—Vomiting—Methotrexate—urinary bladder cancer	0.000207	0.00163	CcSEcCtD
Proguanil—Rash—Methotrexate—urinary bladder cancer	0.000206	0.00161	CcSEcCtD
Proguanil—Dermatitis—Methotrexate—urinary bladder cancer	0.000205	0.00161	CcSEcCtD
Proguanil—Headache—Methotrexate—urinary bladder cancer	0.000204	0.0016	CcSEcCtD
Proguanil—Vomiting—Epirubicin—urinary bladder cancer	0.000194	0.00152	CcSEcCtD
Proguanil—Nausea—Methotrexate—urinary bladder cancer	0.000194	0.00152	CcSEcCtD
Proguanil—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000193	0.00152	CcSEcCtD
Proguanil—Rash—Epirubicin—urinary bladder cancer	0.000192	0.00151	CcSEcCtD
Proguanil—Dermatitis—Epirubicin—urinary bladder cancer	0.000192	0.00151	CcSEcCtD
Proguanil—Headache—Epirubicin—urinary bladder cancer	0.000191	0.0015	CcSEcCtD
Proguanil—Nausea—Epirubicin—urinary bladder cancer	0.000181	0.00142	CcSEcCtD
Proguanil—Vomiting—Doxorubicin—urinary bladder cancer	0.00018	0.00141	CcSEcCtD
Proguanil—Rash—Doxorubicin—urinary bladder cancer	0.000178	0.0014	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—urinary bladder cancer	0.000178	0.0014	CcSEcCtD
Proguanil—Headache—Doxorubicin—urinary bladder cancer	0.000177	0.00139	CcSEcCtD
Proguanil—Nausea—Doxorubicin—urinary bladder cancer	0.000168	0.00132	CcSEcCtD
Proguanil—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	9.76e-05	0.000513	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	9.69e-05	0.000509	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—RB1—urinary bladder cancer	9.66e-05	0.000508	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.64e-05	0.000507	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.63e-05	0.000506	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.56e-05	0.000502	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.5e-05	0.0005	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GSTT1—urinary bladder cancer	9.5e-05	0.0005	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	9.5e-05	0.000499	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	9.22e-05	0.000485	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	8.98e-05	0.000472	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	8.93e-05	0.000469	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	8.9e-05	0.000468	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.89e-05	0.000467	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.86e-05	0.000466	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.78e-05	0.000462	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	8.73e-05	0.000459	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	8.73e-05	0.000459	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CDKN2A—urinary bladder cancer	8.49e-05	0.000447	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	8.44e-05	0.000443	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	8.32e-05	0.000437	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	8.32e-05	0.000437	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	8.28e-05	0.000435	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	8.25e-05	0.000434	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.17e-05	0.000429	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	8.03e-05	0.000422	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NAT1—urinary bladder cancer	8e-05	0.00042	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	8e-05	0.00042	CbGpPWpGaD
Proguanil—DHFR—Metabolism—NQO1—urinary bladder cancer	7.9e-05	0.000415	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	7.76e-05	0.000408	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	7.61e-05	0.0004	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.5e-05	0.000394	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—EP300—urinary bladder cancer	7.39e-05	0.000388	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	7.31e-05	0.000385	CbGpPWpGaD
Proguanil—DHFR—Disease—NCOR1—urinary bladder cancer	7.23e-05	0.00038	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CCND1—urinary bladder cancer	7.18e-05	0.000377	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	7.01e-05	0.000369	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CDKN1A—urinary bladder cancer	6.94e-05	0.000365	CbGpPWpGaD
Proguanil—DHFR—Disease—ERCC2—urinary bladder cancer	6.8e-05	0.000357	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—EP300—urinary bladder cancer	6.61e-05	0.000347	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GSTP1—urinary bladder cancer	6.59e-05	0.000346	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	6.59e-05	0.000346	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	6.51e-05	0.000342	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—MYC—urinary bladder cancer	6.44e-05	0.000338	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.39e-05	0.000336	CbGpPWpGaD
Proguanil—DHFR—Disease—MTHFR—urinary bladder cancer	6.39e-05	0.000336	CbGpPWpGaD
Proguanil—DHFR—Disease—TERT—urinary bladder cancer	6.37e-05	0.000335	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.3e-05	0.000331	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	6.22e-05	0.000327	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	6.17e-05	0.000324	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NAT1—urinary bladder cancer	6.17e-05	0.000324	CbGpPWpGaD
Proguanil—DHFR—Metabolism—TYMS—urinary bladder cancer	6.12e-05	0.000322	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.07e-05	0.000319	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	6.06e-05	0.000319	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GSTM1—urinary bladder cancer	6.05e-05	0.000318	CbGpPWpGaD
Proguanil—DHFR—Metabolism—NCOR1—urinary bladder cancer	6.05e-05	0.000318	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	5.99e-05	0.000315	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	5.93e-05	0.000312	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.87e-05	0.000309	CbGpPWpGaD
Proguanil—DHFR—Disease—FGFR3—urinary bladder cancer	5.85e-05	0.000307	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GPX1—urinary bladder cancer	5.8e-05	0.000305	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.79e-05	0.000304	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MYC—urinary bladder cancer	5.76e-05	0.000303	CbGpPWpGaD
Proguanil—DHFR—Metabolism—ERCC2—urinary bladder cancer	5.69e-05	0.000299	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NAT1—urinary bladder cancer	5.68e-05	0.000298	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	5.68e-05	0.000298	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	5.64e-05	0.000297	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	5.63e-05	0.000296	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NAT1—urinary bladder cancer	5.63e-05	0.000296	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.53e-05	0.000291	CbGpPWpGaD
Proguanil—DHFR—Metabolism—MTHFR—urinary bladder cancer	5.35e-05	0.000281	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	5.19e-05	0.000273	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	5.15e-05	0.00027	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	5.08e-05	0.000267	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	5.07e-05	0.000267	CbGpPWpGaD
Proguanil—DHFR—Disease—CREBBP—urinary bladder cancer	4.98e-05	0.000262	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—TYMP—urinary bladder cancer	4.85e-05	0.000255	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.81e-05	0.000253	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.81e-05	0.000253	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	4.8e-05	0.000252	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.73e-05	0.000249	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TP53—urinary bladder cancer	4.73e-05	0.000249	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	4.68e-05	0.000246	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	4.67e-05	0.000246	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	4.63e-05	0.000244	CbGpPWpGaD
Proguanil—DHFR—Disease—RHOA—urinary bladder cancer	4.5e-05	0.000237	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	4.41e-05	0.000232	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.4e-05	0.000231	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NAT2—urinary bladder cancer	4.38e-05	0.00023	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	4.38e-05	0.00023	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PPARG—urinary bladder cancer	4.34e-05	0.000228	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	4.3e-05	0.000226	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	4.26e-05	0.000224	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CREBBP—urinary bladder cancer	4.17e-05	0.000219	CbGpPWpGaD
Proguanil—DHFR—Disease—ERBB2—urinary bladder cancer	4.17e-05	0.000219	CbGpPWpGaD
Proguanil—DHFR—Disease—PTGS2—urinary bladder cancer	4.07e-05	0.000214	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.96e-05	0.000208	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.91e-05	0.000206	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—RRM2—urinary bladder cancer	3.78e-05	0.000199	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.75e-05	0.000197	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.74e-05	0.000197	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.74e-05	0.000197	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.71e-05	0.000195	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.71e-05	0.000195	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.64e-05	0.000192	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.59e-05	0.000189	CbGpPWpGaD
Proguanil—DHFR—Disease—CDKN1A—urinary bladder cancer	3.56e-05	0.000187	CbGpPWpGaD
Proguanil—DHFR—Disease—PTEN—urinary bladder cancer	3.55e-05	0.000187	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	3.5e-05	0.000184	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ENO2—urinary bladder cancer	3.5e-05	0.000184	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.44e-05	0.000181	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.42e-05	0.00018	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTGS2—urinary bladder cancer	3.41e-05	0.000179	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3.41e-05	0.000179	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	3.4e-05	0.000179	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.39e-05	0.000178	CbGpPWpGaD
Proguanil—DHFR—Disease—EP300—urinary bladder cancer	3.39e-05	0.000178	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.38e-05	0.000178	CbGpPWpGaD
Proguanil—DHFR—Disease—SRC—urinary bladder cancer	3.3e-05	0.000173	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.27e-05	0.000172	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.11e-05	0.000163	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.08e-05	0.000162	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.06e-05	0.000161	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTEN—urinary bladder cancer	2.98e-05	0.000156	CbGpPWpGaD
Proguanil—DHFR—Disease—MYC—urinary bladder cancer	2.95e-05	0.000155	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.92e-05	0.000154	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.92e-05	0.000153	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.91e-05	0.000153	CbGpPWpGaD
Proguanil—DHFR—Disease—EGFR—urinary bladder cancer	2.89e-05	0.000152	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.89e-05	0.000152	CbGpPWpGaD
Proguanil—DHFR—Metabolism—EP300—urinary bladder cancer	2.84e-05	0.000149	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NQO1—urinary bladder cancer	2.82e-05	0.000148	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.81e-05	0.000148	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.8e-05	0.000147	CbGpPWpGaD
Proguanil—DHFR—Disease—KRAS—urinary bladder cancer	2.73e-05	0.000143	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.7e-05	0.000142	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.7e-05	0.000142	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.69e-05	0.000141	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.68e-05	0.000141	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.66e-05	0.00014	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.63e-05	0.000138	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.62e-05	0.000138	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.58e-05	0.000136	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.49e-05	0.000131	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.49e-05	0.000131	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.46e-05	0.00013	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.46e-05	0.00013	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.45e-05	0.000129	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.41e-05	0.000127	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.39e-05	0.000126	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	2.36e-05	0.000124	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.35e-05	0.000124	CbGpPWpGaD
Proguanil—DHFR—Disease—HRAS—urinary bladder cancer	2.32e-05	0.000122	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.27e-05	0.00012	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.25e-05	0.000118	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.19e-05	0.000115	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.18e-05	0.000115	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.16e-05	0.000114	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.16e-05	0.000114	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.11e-05	0.000111	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.11e-05	0.000111	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.11e-05	0.000111	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.09e-05	0.00011	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.07e-05	0.000109	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.04e-05	0.000107	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.03e-05	0.000107	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.03e-05	0.000107	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.01e-05	0.000106	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2e-05	0.000105	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.99e-05	0.000104	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.93e-05	0.000101	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.91e-05	0.000101	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.84e-05	9.69e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.82e-05	9.55e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.76e-05	9.24e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.75e-05	9.23e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.7e-05	8.92e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.69e-05	8.88e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.68e-05	8.84e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.67e-05	8.79e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.67e-05	8.78e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.67e-05	8.78e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.66e-05	8.71e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.65e-05	8.66e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.63e-05	8.54e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.63e-05	8.54e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.6e-05	8.43e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.6e-05	8.41e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.58e-05	8.29e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.57e-05	8.25e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.55e-05	8.17e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.55e-05	8.15e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.54e-05	8.1e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.54e-05	8.07e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.54e-05	8.07e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.52e-05	8e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.52e-05	8e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.49e-05	7.83e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.48e-05	7.76e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.47e-05	7.73e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.46e-05	7.66e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.44e-05	7.59e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.44e-05	7.55e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.43e-05	7.52e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.42e-05	7.44e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.37e-05	7.2e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.36e-05	7.13e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.35e-05	7.07e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.32e-05	6.92e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.31e-05	6.89e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.3e-05	6.84e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.3e-05	6.84e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.25e-05	6.55e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.22e-05	6.43e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.22e-05	6.41e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.2e-05	6.29e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.15e-05	6.04e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.15e-05	6.04e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.1e-05	5.79e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.09e-05	5.74e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.09e-05	5.74e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.06e-05	5.59e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.06e-05	5.56e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.05e-05	5.51e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.02e-05	5.34e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.01e-05	5.33e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1e-05	5.28e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1e-05	5.28e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.62e-06	5.05e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.44e-06	4.96e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	9.41e-06	4.95e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PPARG—urinary bladder cancer	9.32e-06	4.9e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	8.96e-06	4.71e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.87e-06	4.66e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	8.66e-06	4.55e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	8.58e-06	4.51e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTEN—urinary bladder cancer	8.21e-06	4.32e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—EP300—urinary bladder cancer	7.83e-06	4.12e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTEN—urinary bladder cancer	7.55e-06	3.97e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTEN—urinary bladder cancer	7.49e-06	3.93e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	7.33e-06	3.86e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—EP300—urinary bladder cancer	7.2e-06	3.79e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.2e-06	3.78e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—EP300—urinary bladder cancer	7.14e-06	3.75e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.91e-06	3.63e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTEN—urinary bladder cancer	6.4e-06	3.36e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—EP300—urinary bladder cancer	6.1e-06	3.21e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.66e-06	2.98e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.94e-06	2.6e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.71e-06	2.47e-05	CbGpPWpGaD
